In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EpiTherapeutics APS

Division of Gilead Sciences Inc.

Latest From EpiTherapeutics APS

What's Next On Gilead's Shopping List

With much of its cash held ex-US, Gilead is unlikely to undertake another large acquisition soon, even if there are logical reasons to bolster its NASH pipeline or try to acquire partner Galapagos. Firm is likely to follow Kite buyout with targeted cancer deals.

Business Strategies M & A

Deals Shaping The Medical Industry, June 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in May 2015.

BioPharmaceutical Medical Device

Start-Up Execs On The Move, December 2013

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

BioPharmaceutical Medical Device

Merck Serono Ventures, Compugen Team Up On Drug Toxicity Biomarker Start-Up

Partnership is first investment under Merck Serono Ventures’ €10 million Israel Bioincubator Program.

Medical Device Germany
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Denmark
  • Parent & Subsidiaries
  • Gilead Sciences Inc.
  • Senior Management
  • Martin Bonde, CEO
    Henrik Blou, Dir., Bus. Dev.
    Lars-Ole Gerlach, EVP, R&D
  • Contact Info
  • EpiTherapeutics APS
    Phone: (45) 2025 3560
    Ole Maaløesvej 3
    Copenhagen, DK-2200